Urinary Incontinence News and Research

RSS
Urinary incontinence (UI), or the unintentional loss of urine, is a problem for more than 13 million Americans—85 percent of them women. Although about half of the elderly have episodes of incontinence, bladder problems are not a natural consequence of aging, and they are not exclusively a problem of the elderly.

Incontinence has several causes. Women are most likely to develop incontinence either during pregnancy and childbirth, or after the hormonal changes of menopause, because of weakened pelvic muscles. Older men can become incontinent as the result of prostate surgery. Pelvic trauma, spinal cord damage, caffeine, or medications including cold or over-the-counter diet tablets also can cause episodes of incontinence.

But even though urinary incontinence can be improved in 8 out of 10 cases, fewer than half of those with bladder problems ever discuss the condition with their health care professional. The condition often goes untreated.
Novel device for measuring pelvic floor muscle strength

Novel device for measuring pelvic floor muscle strength

Women more likely to experience UI following vaginal delivery

Women more likely to experience UI following vaginal delivery

New embolization procedure may bring hope to men with enlarged prostate

New embolization procedure may bring hope to men with enlarged prostate

CBT, PE can ameliorate treatment-induced menopausal symptoms in breast cancer patients

CBT, PE can ameliorate treatment-induced menopausal symptoms in breast cancer patients

NAFC honors VUMC nurse practitioner with Rodney Appell Continence Care Champion Award

NAFC honors VUMC nurse practitioner with Rodney Appell Continence Care Champion Award

New UCLA Alzheimer's and Dementia Care program for patients, caregivers

New UCLA Alzheimer's and Dementia Care program for patients, caregivers

Botox - a potential for therapy of weak bladders in women

Botox - a potential for therapy of weak bladders in women

Botulinum toxin effective in treating OAB among women

Botulinum toxin effective in treating OAB among women

Endo fourth quarter total revenues increase 57% to $803.4 million

Endo fourth quarter total revenues increase 57% to $803.4 million

U.S. FDA accepts Pfizer's tafamidis NDA for treatment of TTR-FAP

U.S. FDA accepts Pfizer's tafamidis NDA for treatment of TTR-FAP

Link between vitamin D deficiency and urinary incontinence

Link between vitamin D deficiency and urinary incontinence

Top-line primary endpoint data from Pfizer's Toviaz trial on overactive bladder

Top-line primary endpoint data from Pfizer's Toviaz trial on overactive bladder

Women with overactive bladder invited for virtual research study

Women with overactive bladder invited for virtual research study

EC approves Pfizer's Vyndaqel to treat Transthyretin Familial Amyloid Polyneuropathy

EC approves Pfizer's Vyndaqel to treat Transthyretin Familial Amyloid Polyneuropathy

New possibilities for relief from digestive diseases

New possibilities for relief from digestive diseases

Pfizer's Toviaz Study A0221048 for overactive bladder meets primary endpoint

Pfizer's Toviaz Study A0221048 for overactive bladder meets primary endpoint

NIH selects Women & Infants to participate in Pelvic Floor Disorders Network

NIH selects Women & Infants to participate in Pelvic Floor Disorders Network

Highly prevalent urinary and bladder symptoms will increase further

Highly prevalent urinary and bladder symptoms will increase further

Boston Scientific releases statement on safety, effectiveness of surgical mesh for POP and SUI

Boston Scientific releases statement on safety, effectiveness of surgical mesh for POP and SUI

Cryo-Save introduces unique service for the U.S. people to store adipose-derived stem cells

Cryo-Save introduces unique service for the U.S. people to store adipose-derived stem cells